Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist

European Journal of Pharmacology

Volumn 295, Issue 2-3, 1996, Pages 137-146

  Tzschentke, Thomas M ^a   Schmidt, Werner J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

AMPA receptor; Catalepsy; Catatonia; CGP 37849; GYKI 52466; MK 801; Morphine; NMDA receptor

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; TECHNIQUE;

EID: 0030048455     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00667-2     Document Type: Article

References (39)

1. Babbini, M. and W.M. Davis, 1972, Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment, Br. J. Pharmacol. 46, 213.
2. Bechara, A. and D. Van der Kooy, 1992, Lesions of the tegmental pedunculopontine nucleus: effects on the locomotor activity induced by morphine and amphetamine, Pharmacol. Biochem. Behav. 42, 9.
3. Broekkamp, C.L., M. LePichon and K.G. Lloyd. 1984, Akinesia after locally applied morphine near the nucleus raphe pontis of the rat, Neurosci. Lett. 50, 313.
4. Bubser, M., U. Keseberg, P.K. Notz and W.J. Schmidt, 1992, Differential behavioural effects of competitive and non-competitive NMDA receptor antagonists in rats, Eur. J. Pharmacol. 229, 75.
5. Carlsson, A., 1993, On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity, J. Neural Transm. (Suppl.) 40, 1.
6. Carlsson, M. and A. Carlsson, 1990, Interactions between glutamatergic and monoaminergic systems within the basal ganglia -implications for schizophrenia and Parkinson's disease, Trends Neurosci. 13, 272.
7. Costall, B., D.H. Fortune and R.J. Naylor, 1978, The induction of catalepsy and hyperactivity by morphine administered directly into the nucleus accumbens of rats, Eur. J. Pharmacol. 49, 49.
8. De Ryck, M. and P. Teitelbaum, 1984, Morphine catalepsy as an adaptive reflex state in rats, Behav. Neurosci. 98, 243.
9. De Ryck, M., T. Schallert and P. Teitelbaum, 1980, Morphine versus haloperidol catalepsy in the rat: a behavioral analysis of postural support mechanisms, Brain Res. 201, 143.
10. Hauber, W. and R. Andersen, 1993, The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine, Naunyn-Schmied. Arch. Pharmacol. 348, 486.
11. Havemann, U. and K. Kuschinsky, 1981, Further characterization of opioid receptors in the striatum mediating muscular rigidity in rats, Naunyn-Schmied. Arch. Pharmacol. 317, 321.
12. Havemann, U., M. Winkler and K. Kuschinsky, 1980, Opioid receptors in the caudate nucleus can mediate EMG-recorded rigidity in rats, Naunyn-Schmied. Arch. Pharmacol. 313, 139.
13. Jeziorski, M., F.J. White and M.E. Wolf, 1994, MK-801 prevents the development of behavioral sensitization during repeated morphine administration, Synapse 16, 137.
14. Jolicoeur, F.B. and R. Rivest, 1992, Rodent models of Parkinson's disease, Neuromethods 21, 135.
15. Klockgether, T. and L. Turski, 1993, Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia, Ann. Neurol. 34, 585.
16. Kötter, R., 1994, Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum, Prog. Neurobiol. 44, 163.
17. Kretschmer, B.D., B. Zadow, T.L. Volz, L. Volz and W.J. Schmidt, 1992, The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior, J. Neural Transm. [GenSect] 87, 23.
18. Layer, R.T., N.J. Uretsky and L.J. Wallace, 1993, Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference, Brain Res. 617, 267.
19. Martin, W.R., 1984, Pharmacology of opioids, Pharmacol. Rev. 35, 283.
20. Mehta, A.K. and M.K. Ticku, 1990, Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats, Life Sci. 46, 37.
21. Olmstead, M.C. and K.B.J. Franklin, 1994, Lesions of the pedunculopontine tegmental nucleus abolish catalepsy and locomotor depression induced by morphine, Brain Res. 662, 134.
22. Petit, F., M. Hamon, M.C. Fournie-Zaluski, B.P. Roques and J. Glowinski, 1986, Further evidence for a role of delta-opiate receptors in the presynaptic regulation of newly synthesized dopamine release, Eur. J. Pharmacol. 126, 1.
23. Pollard, H., C. Llorens, J.J. Bonnet, J. Costentin and J.C. Schwartz, 1977a, Opiate receptors on mesolimbic dopaminergic neurons, Neurosci. Lett. 7, 295.
24. Pollard, H., C. Llorens-Cortes and J.C. Schwartz, 1977b, Enkephalin receptors on dopaminergic neurones in rat striatum, Nature 268, 745.
25. Rattan, A.K. and P. Sribanditmongkol, 1994, Effect on morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat, Pharmacol. Biochem. Behav. 48, 357.
26. Sanberg, P.R., M.D. Bunsey, M. Giordano and A.B. Norman, 1988, The catalepsy test: its ups and downs, Behav. Neurosci. 102, 748.
27. Schmidt, W.J. and M. Bubser, 1989, Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats, Pharmacol. Biochem. Behav. 32, 621.
28. Schmidt, W.J. and D. Bury, 1988, Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat, Life Sci. 43, 545.
29. Schmidt, W.J., B. Zadow, B.D. Kretschmer and W. Hauber, 1991, Anticataleptic potencies of glutamate-antagonists, Amino Acids 1, 225.
30. Schmidt, W.J., M. Bubser and W. Hauber, 1992, Behavioural pharmacology of glutamate in the basal ganglia, J. Neural Transm. (Suppl.) 38, 65.
31. Trovero, F., D. Herve, M. Desban, J. Glowinski and J.P. Tassin, 1990, Striatal opiate mu-receptors are not located on dopamine nerve endings in the rat, Neuroscience 39, 313.
32. Trujillo, K.A. and H. Akil, 1991, The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality, Pharmacol. Biochem. Behav. 38, 673.
33. Tucci, S., R. Fernandez, T. Baptista, E. Murzi and L. Hernandez, 1994, Dopamine release in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats, Brain Res. Bull. 35, 125.
34. Turski, L., U. Havemann and K. Kuschinsky, 1982, Evidence for functional interactions of morphine in substantia nigra and striatum in relation to muscular rigidity in rats, Neurosci. Lett. 28, 291.
35. Wardas, J., K. Ossowska and S. Wolfarth, 1987, The role of gamma-aminobutyric acid mechanisms of the zona incerta-lateral hypothalamus in the catalepsy and muscle rigidity evoked by morphine, Brain Res. 408, 363.
36. Weinger, M.B. and J M. Bednarczyk, 1994, Atipamezole, an alpha2 antagonist, augments opiate-induced muscle rigidity in the rat, Pharmacol. Biochem. Behav. 49, 523.
37. Weinger, M.B., D.Y. Chen, T. Lin, C. Lau, G.F. Koob and N.T. Smith, 1995, A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat, Brain Res. 669, 10.
38. Winkler, M., U. Havemann and K. Kuschinsky, 1982, Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats, Naunyn-Schmied. Arch. Pharmacol. 318, 143.
39. Zadow, B. and W.J. Schmidt, 1994, The AMPA antagonists NBQX and GYKI 52466 do not counteract neuroleptic-induced catalepsy, Naunyn-Schmied. Arch. Pharmacol. 349.